Bénédicte Deau

2.7k total citations
43 papers, 476 citations indexed

About

Bénédicte Deau is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Bénédicte Deau has authored 43 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 10 papers in Genetics. Recurrent topics in Bénédicte Deau's work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Bénédicte Deau is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Bénédicte Deau collaborates with scholars based in France, Belgium and United States. Bénédicte Deau's co-authors include Olivier Hermine, Richard Delarue, Patrick Mayeux, Dominique Dumènil, Nicole Brousse, Florence Margottin-Goguet, Frédèrique Verdier, Catherine Lacombe, Felipe Suárez and Marie‐Olivia Chandesris and has published in prestigious journals such as Blood, PLoS ONE and Transplantation.

In The Last Decade

Bénédicte Deau

39 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bénédicte Deau France 12 190 169 118 100 96 43 476
Filiz Şen United States 16 278 1.5× 213 1.3× 124 1.1× 163 1.6× 117 1.2× 42 623
Michio Sawada Japan 15 302 1.6× 207 1.2× 152 1.3× 91 0.9× 61 0.6× 37 577
Tommasina Perrone Italy 14 245 1.3× 183 1.1× 154 1.3× 85 0.8× 186 1.9× 41 562
Francesca Gaia Rossi Italy 12 118 0.6× 189 1.1× 241 2.0× 140 1.4× 180 1.9× 32 615
Nathalie Aladjidi France 14 186 1.0× 167 1.0× 171 1.4× 84 0.8× 266 2.8× 53 615
Peter Waldron United States 13 79 0.4× 117 0.7× 109 0.9× 145 1.4× 169 1.8× 30 641
Jean Michel Picquenot France 8 318 1.7× 264 1.6× 111 0.9× 68 0.7× 29 0.3× 11 598
Annunziata Manna Italy 10 228 1.2× 174 1.0× 138 1.2× 98 1.0× 139 1.4× 29 485
Takuya Komeno Japan 13 118 0.6× 114 0.7× 175 1.5× 166 1.7× 278 2.9× 49 595
Archrob Khuhapinant Thailand 11 201 1.1× 160 0.9× 118 1.0× 261 2.6× 209 2.2× 37 550

Countries citing papers authored by Bénédicte Deau

Since Specialization
Citations

This map shows the geographic impact of Bénédicte Deau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bénédicte Deau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bénédicte Deau more than expected).

Fields of papers citing papers by Bénédicte Deau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bénédicte Deau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bénédicte Deau. The network helps show where Bénédicte Deau may publish in the future.

Co-authorship network of co-authors of Bénédicte Deau

This figure shows the co-authorship network connecting the top 25 collaborators of Bénédicte Deau. A scholar is included among the top collaborators of Bénédicte Deau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bénédicte Deau. Bénédicte Deau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Molinari, Nicolas, David Sibon, Anne‐Ségolène Cottereau, et al.. (2023). Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA. British Journal of Haematology. 202(2). 379–383.
4.
Zerbit, Jérémie, Antoine Meyer, Justine Decroocq, et al.. (2022). Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses. 14(11). 2377–2377. 15 indexed citations
5.
Manson, Guillaume, Pauline Brice, Charles Herbaux, et al.. (2020). Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(4). 1144–1153. 5 indexed citations
6.
Contejean, Adrien, Fréderique Larousserie, Didier Bouscary, et al.. (2020). A colonic mass revealing a disseminated crystal storing histiocytosis secondary to indolent multiple myeloma: a case report with literature review. BMC Gastroenterology. 20(1). 239–239. 3 indexed citations
7.
Mondésir, Johanna, David Sibon, Lise Willems, et al.. (2019). Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study. British Journal of Haematology. 187(1). 65–72. 1 indexed citations
8.
Deau, Bénédicte, et al.. (2019). Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases. Cancer/Radiothérapie. 23(3). 232–239. 9 indexed citations
9.
Deau, Bénédicte, Sandy Amorim, Aurore Perrot, et al.. (2018). Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study. British Journal of Haematology. 181(3). 341–349. 7 indexed citations
10.
Grignano, Éric, Bénédicte Deau, Gokoulakrichenane Loganadane, et al.. (2018). Radiotherapy of relapse-refractory follicular lymphoma. Cancer/Radiothérapie. 22(2). 126–130. 5 indexed citations
11.
Mallet, Vincent, Rébecca Sberro‐Soussan, Anne‐Marie Roque‐Afonso, et al.. (2018). Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients. Transplantation. 102(8). 1351–1357. 11 indexed citations
12.
Hadjadj, Jérôme, Wendy Cuccuini, Bénédicte Deau, et al.. (2017). Uterine intravascular lymphoma as a cause of fever of unknown origin. Annals of Hematology. 96(11). 1891–1896. 3 indexed citations
13.
Willems, Lise, Bénédicte Deau, Sylvain Pilorge, et al.. (2016). Polyserositis in the course of chronic myelomonocytic leukemia: impact of hypomethylating agents. 2(1). 126–130. 2 indexed citations
14.
Sibon, David, Franck Morschhauser, Matthieu Resche‐Rigon, et al.. (2015). Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica. 101(4). 474–481. 28 indexed citations
15.
London, Jonathan, A. Grados, Christophe Fermé, et al.. (2014). Sarcoidosis Occurring After Lymphoma. Medicine. 93(21). e121–e121. 45 indexed citations
16.
Neste, Eric Van Den, Olivier Casasnovas, Marc André, et al.. (2013). Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant. Haematologica. 98(8). 1185–1195. 35 indexed citations
17.
Roux, J., Maxime Battistella, Luc Matthieu Fornecker, et al.. (2012). Human Herpesvirus-6 Cytopathic Inclusions. American Journal of Dermatopathology. 34(6). e73–e76. 9 indexed citations
18.
Chandesris, Marie‐Olivia, Georgia Malamut, Virginie Verkarre, et al.. (2010). Enteropathy-associated T-cell lymphoma: A review on clinical presentation, diagnosis, therapeutic strategies and perspectives. Gastroentérologie Clinique et Biologique. 34(11). 590–605. 35 indexed citations
19.
Canioni, Danielle, Bénédicte Deau, Pierre Taupin, et al.. (2009). Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases. PLoS ONE. 4(7). e6341–e6341. 31 indexed citations
20.
Deau, Bénédicte, et al.. (2006). Acute monocytic leukemia with coexpression of minor BCRABL1 and PICALMMLLT10 fusion genes along with overexpression of HOXA9. Genes Chromosomes and Cancer. 45(6). 575–582. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026